EverHint – SMA 20/50 Crossover – Top 11 Buy and Top 5 Sell Signals for Jul 01, 2026
What This Signal Is
Detects fresh crossovers between the 20-day simple moving average (SMA20) and the 50-day simple moving average (SMA50). Uses two SMAs, making it more stable and less prone to false signals compared to EMA-based strategies. Well-suited for identifying medium-term trend changes with higher reliability.
Entry Criteria:
- Buy: SMA20 crosses above SMA50
- Sell: SMA20 crosses below SMA50
- Minimum ADV: $40M (liquidity filter)
- Earnings buffer: 7 days pre/post earnings
- Fresh crossover: Detected on today's close
Holding period: 2-6 weeks | Risk level: Medium
Market Context
Equity markets are showing mild broad-based softness heading into July 1, 2026, with the Nasdaq leading declines at -0.64% compared to the relatively flat Dow Jones at -0.03%. This divergence suggests some rotation away from growth and technology-oriented names, though the moves remain contained rather than indicative of aggressive risk-off sentiment. The S&P 500's modest -0.19% dip reflects a market that is pausing rather than reversing, which is a relevant backdrop for trend-following strategies like the SMA20/SMA50 crossover system.
Volatility, as measured by the VIX at 16.38 and itself declining slightly (-0.43%), sits in a moderate and well-contained range. This level is generally constructive for trend-following signals — low enough that intraday noise is unlikely to trigger false breakouts, yet not so suppressed that momentum becomes stale or directionless. SMA crossover strategies tend to perform best when price action is orderly and sustained, conditions that a sub-17 VIX environment broadly supports.
With Technology emerging as the top sector for today's 17 signals despite the Nasdaq's relative underperformance, there is an interesting tension worth monitoring. The sector may be experiencing short-term profit-taking within a longer-term uptrend, which is precisely the kind of environment where SMA20/SMA50 crossovers can identify meaningful trend continuations versus temporary pullbacks. Traders should remain attentive to whether the Nasdaq's relative weakness deepens, as a sustained technology sector rotation could reduce the reliability of bullish crossover signals concentrated in that space.
🟢 Buy Signals (11 of 11 total)
Ranked by RSI (lower RSI = more oversold for buy signals)
| # | Ticker | Company | Sector | Price | Insider | MCap |
|---|---|---|---|---|---|---|
| 1 | ACHC | Acadia Healthcare Comp... | Healthcare | $31.25 | — | $2.9B |
| 2 | AROC | Archrock, Inc. | Energy | $38.76 | -$3,306,600 | $6.8B |
| 3 | CHH | Choice Hotels Internat... | Consumer Cyclical | $109.27 | -$175,039 | $5.0B |
| 4 | CLDX | Celldex Therapeutics, ... | Healthcare | $36.78 | — | $2.4B |
| 5 | EGP | EastGroup Properties, ... | Real Estate | $205.46 | — | $11.0B |
| 6 | FSS | Federal Signal Corpora... | Industrials | $127.59 | — | $7.8B |
| 7 | IDA | IDACORP, Inc. | Utilities | $150.12 | — | $8.3B |
| 8 | PRI | Primerica, Inc. | Financial Services | $291.63 | — | $9.1B |
| 9 | RJF | Raymond James Financia... | Financial Services | $158.19 | — | $30.8B |
| 10 | SRRK | Scholar Rock Holding C... | Healthcare | $52.84 | -$3,147,535 | $6.3B |
| 11 | WELL | Welltower Inc. | Real Estate | $230.19 | — | $162.5B |
🔴 Sell Signals (5 of 6 total)
Ranked by RSI (lower RSI = more oversold for buy signals)
| # | Ticker | Company | Sector | Price | Insider | MCap |
|---|---|---|---|---|---|---|
| 1 | AKAM | Akamai Technologies, Inc. | Technology | $112.81 | — | $16.4B |
| 2 | MCHP | Microchip Technology I... | Technology | $88.69 | — | $48.1B |
| 3 | PATH | UiPath Inc. | Technology | $11.55 | — | $6.1B |
| 4 | SCCO | Southern Copper Corpor... | Basic Materials | $168.80 | -$724 | $140.8B |
| 5 | UNFI | United Natural Foods, ... | Consumer Defensive | $45.68 | -$765,564 | $2.8B |
Field Notes
Sector concentration: Technology (4), Healthcare (3), Real Estate (2)
Insider selling: UNFI (United Natural Foods, Inc., -$765,564), SCCO (Southern Copper Corporation, -$724), CHH (Choice Hotels International, Inc., -$175,039)
Data coverage: 41.2% insider, 0.0% congressional, 0.0% earnings, 23.5% news
Peer Analysis
PATH (UiPath Inc.): Leads 5 peers: WIX ($48.88), DBX ($28.41), KVYO ($16.36), DOX ($51.18), NICE ($94.83)
ACHC (Acadia Healthcare Company, Inc.): Leads 5 peers: NHC ($212.71), MD ($26.14), ARDT ($10.13), AVAH ($8.86), LFST ($11.43)
AKAM (Akamai Technologies, Inc.): Leads 5 peers: DOX ($51.18), PAYC ($133.96), IDCC ($282.26), PEGA ($31.09), SAIL ($15.31)
UNFI (United Natural Foods, Inc.): Leads 5 peers: CHEF ($95.36), MH ($10.35), SAM ($177.63), COCO ($68.98), CCU ($10.80)
CHH (Choice Hotels International, Inc.): Leads 5 peers: TNL ($75.19), WH ($83.60), SLGN ($46.11), KBH ($60.62), CVCO ($601.89)
Recent Headlines
AKAM (Akamai Technologies, Inc.)
- Akamai Technologies (AKAM) Sees a More Significant Dip Than Broader Market: Some Facts to Know
- Cybersecurity Stock Flashing Bull Signal After Pullback
AROC (Archrock, Inc.)
- Archrock Inc. (AROC) Stock Slides as Market Rises: Facts to Know Before You Trade
- These 2 Oils and Energy Stocks Could Beat Earnings: Why They Should Be on Your Radar
- Archrock Appoints Mohit Singh Senior Vice President and Chief Financial Officer
PATH (UiPath Inc.)
- UiPath Broadens Enterprise Automation Ambitions With Maestro Case
- UiPath vs. Nu Holdings: Which Disruptive Growth Stock is a Buy?
PRI (Primerica, Inc.)
- Designer Rachel Zoe and Aflac make fashion statement to urge Americans to check for cancer
Vlad's Take
Today's signals: Strong sector concentration in Technology (4 signals) suggests sector-specific rotation. 5 signals showing insider selling warrant caution.
Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.
This is not financial advice. Market conditions change rapidly.
Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/
📢 Enjoying the updates? Liking, sharing, or subscribing helps bring this analysis to a wider audience.